Govt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia

Published On 2020-01-17 06:30 GMT   |   Update On 2020-01-17 06:30 GMT

New Delhi: The government may impose anti-dumping duty on a chemical used in pharma and pesticide industries from China and Saudi Arabia with a view to guard domestic players from cheap imports. The commerce ministry's investigation arm Directorate General of Trade Remedies (DGTR) has initiated a probe into alleged dumping of Dimethyl Formamide from these two countries following a complaint filed by Balaji Amines Ltd on behalf of domestic industry.

The company has filed an application before the directorate for an investigation into the imports from these countries for imposing the anti-dumping duty.

DGTR in a notification said on the basis of the prima facie evidence submitted by the company about dumping of the product by firms in these two nations, " the authority, hereby, initiates an investigation".

In the probe, DGTR will determine the existence, degree and effect of any alleged dumping.

If it will be established that the dumping has impacted the domestic industry, the directorate would recommend imposition of the duty. The finance ministry will take the final decision to impose duty.

The period of investigation is from January to September 2019 (9 months). It would also look at the data of 2016-19.

Countries carry out anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in cheap imports. As a countermeasure, they impose duties under the multilateral regime of the World Trade Organisation.

Read also: CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

The duty is aimed at ensuring fair trade practices and creating a level-playing field for domestic producers with regard to foreign producers and exporters.

Read also: JB Chemicals Q2 PAT jumps 82 pc at Rs 94 crore


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News